neurogal
Bluelighter
I recently learned there are several antidepressants in trials that act on opiate receptors while blocking highly pleasurable sensations in order to reduce addiction/abuse. One in particular that I'm interested in is currently known as CERC 501 (bupe/samidorphan). Unfortunately it's been essentially shot down for now by the FDA for trial methodology issues among other concerns. Has anyone researched or been following ADs involving opiate receptor(s)? Kappa blockers are of particular interest.
Last edited:
